Researcher Profile Statistics: Rama, Ana Cristina
Geo Map
Region
#
NA - North America
39
AS - Asia, other
12
EU - Europe
5
OC - Oceania
1
Unknown
2
Total
59
Country
#
US - United States of America
39
SG - Singapore
7
CN - China
4
IE - Ireland
2
AU - Australia
1
DE - Germany
1
GB - United Kingdom
1
ID - Indonesia
1
PT - Portugal
1
Unknown
2
Total
59
City
#
New York
8
Ashburn
7
Hanover
4
Singapore
4
Dublin
2
Inglewood
2
Shanghai
2
Canberra
1
Coimbra
1
Jakarta
1
other
27
Total
59
Most viewed items
#
ID: 62798 - Development and stability assessment of liquid paediatric formulations containing sildenafil citrate
59
Total
59
Most type viewed
#
ID: all -
59
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: book -
0
ID: thesis -
0
ID: selected -
0
Total
59
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2023
0 0
0 0 0 0
0 0 0 3
8 7
18
2024
3 2
3 12 9 5
2 5 0 0
0 0
41
Ever
59
Geo Map
Region | # |
---|---|
NA - North America | 39 |
AS - Asia, other | 12 |
EU - Europe | 5 |
OC - Oceania | 1 |
Unknown | 2 |
Total | 59 |
Country | # |
---|---|
US - United States of America | 39 |
SG - Singapore | 7 |
CN - China | 4 |
IE - Ireland | 2 |
AU - Australia | 1 |
DE - Germany | 1 |
GB - United Kingdom | 1 |
ID - Indonesia | 1 |
PT - Portugal | 1 |
Unknown | 2 |
Total | 59 |
City | # |
---|---|
New York | 8 |
Ashburn | 7 |
Hanover | 4 |
Singapore | 4 |
Dublin | 2 |
Inglewood | 2 |
Shanghai | 2 |
Canberra | 1 |
Coimbra | 1 |
Jakarta | 1 |
other | 27 |
Total | 59 |
Most viewed items | # |
---|---|
ID: 62798 - Development and stability assessment of liquid paediatric formulations containing sildenafil citrate | 59 |
Total | 59 |
Most type viewed | # |
---|---|
ID: all - | 59 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: book - | 0 |
ID: thesis - | 0 |
ID: selected - | 0 |
Total | 59 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 8 | 7 | 18 |
2024 | 3 | 2 | 3 | 12 | 9 | 5 | 2 | 5 | 0 | 0 | 0 | 0 | 41 |
Ever | 59 |